scispace - formally typeset
R

Ritu Trivedi

Researcher at Central Drug Research Institute

Publications -  114
Citations -  3435

Ritu Trivedi is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Osteoblast & Bone remodeling. The author has an hindex of 28, co-authored 108 publications receiving 2721 citations. Previous affiliations of Ritu Trivedi include AMIT & Council of Scientific and Industrial Research.

Papers
More filters
Journal ArticleDOI

Estrogen deficiency induces the differentiation of IL-17 secreting Th17 cells: a new candidate in the pathogenesis of osteoporosis.

TL;DR: IL-17 plays a critical causal role in Ovx-induced bone loss and may be considered a potential therapeutic target in pathogenesis of post menopausal osteoporosis.
Journal ArticleDOI

Kaempferol has osteogenic effect in ovariectomized adult Sprague-Dawley rats.

TL;DR: It is shown that K is non-estrogenic in vivo and exerts bone anabolic activity with attendant inhibition of bone marrow adipogenesis, and exhibits no estrogenicity at the uterine level.
Journal ArticleDOI

miR-542-3p suppresses osteoblast cell proliferation and differentiation, targets BMP-7 signaling and inhibits bone formation

TL;DR: It is shown that miR-542-3p, a well-characterized tumor suppressor whose downregulation is tightly associated with tumor progression via C-src-related oncogenic pathways, inhibits osteoblast proliferation and differentiation and inhibits BMP-7-mediated osteogenesis.
Journal ArticleDOI

Vitamin B12 functionalized layer by layer calcium phosphate nanoparticles: A mucoadhesive and pH responsive carrier for improved oral delivery of insulin.

TL;DR: The study highlighted the role of VitB12 as a pH sensitive and targeting ligand which significantly participated in enhancing insulin oral bioavailability and multiple pathways to improve the overall bioavailability of insulin including paracellular transport and receptor mediated endocytosis.